Samsung Biologics삼성바이오로직스
207940 · KOSPI · ₩SBL · 삼성바이오로직스
Technical gauge
After the close on Oct 26, 2026Short term
Bullish
7 bullish, 2 neutral, 0 bearish
Medium term
Neutral
4 bullish, 0 neutral, 4 bearish
What the indicators say
Samsung Biologics closed at 1,452,000 won, above its 5-day (1,417,400) and 20-day (1,338,950) moving averages but slightly below its 60-day (1,444,033.3) and 200-day (1,521,955) averages, with the 200-day still overhead. Short-term gauges read bullish (7 bull versus 0 bear) with RSI at 57.5, stochastic at 85.6, and MACD histogram positive, while the medium-term gauge is neutral (4 bull, 4 bear) and ADX at 26.7 with +DI 29.7 above -DI 17.4 points to a firm trend. Recent events include a breakdown below support on 2026-10-07 and 2026-10-08 followed by a breakout above resistance on 2026-10-23 on 1.6× volume, and the key levels are support at 1,406,000 won and resistance at 1,456,000 won.
Written by AI from the indicator values above. Not advice.
Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Squeeze! setup
1D timeframeNo squeeze setup on this stock right now.
Chart
2026-10-26O 1,446,000H 1,489,000L 1,441,000C 1,452,000
Every indicator, chart overlays and the stock's recent technical events, with Pro.Unlock with Pro →
Indicators
- Moving averagesPrice above 4 of 5 averages5d ₩1,417,400 · 20d ₩1,338,950 · 60d ₩1,444,033 · 120d ₩1,417,025 · 200d ₩1,521,955Price above its averages is commonly read as an uptrend, below as a downtrend; the 200-day line is widely watched for the long-term trend.
- RSI (14)Upward momentum57.5Measures the speed of recent gains vs losses. Above 70 is often called overbought, below 30 oversold; extremes can last in strong trends.
- MACD (12, 26, 9)Above its signal line532 · signal -25,469 · histogram 26,001The gap between 12- and 26-day exponential averages. Crossing its signal line is read as momentum turning; above zero, the short-term average is above the long.
- Bollinger Bands (20, 2)Inside the bands₩1,163,382 – ₩1,338,950 – ₩1,514,518 · width 26.2%Bands two standard deviations around the 20-day average. A squeeze (very narrow bands) means unusually quiet trading, which often comes before a bigger move either way.
- Volume vs 20-day averageLight trading0.43×Trading volume compared with its 20-day average. Moves on heavy volume are usually given more weight.
Every indicator, chart overlays and the stock's recent technical events, with Pro.
Unlock with ProTechnical events, last 90 days
Every indicator, chart overlays and the stock's recent technical events, with Pro.
Unlock with ProShort squeeze tracker
Score hidden
Sign in free to track one stock with the full squeeze tracker.
See the short squeeze score on your watchlist stocks with Pro.Unlock with Pro →or add Squeeze Pro (US$49/month) →
Estimates from short-selling data. Levels are not predictions or trading recommendations.
Share lending and returned shares
Shares lent out (mostly to short sellers), new loans and shares returned each day. A return is either the lender calling the shares back (a recall) or the borrower handing them back, often after buying back a short. The published figures don't say which.
- Shares on loan
- 758K
- 1.6% of listed shares
- Loans, 5-day change
- +3.6%
- Loans, 20-day change
- +9.5%
- Returned, last 5 days
- 114.4K
- New loans, last 5 days
- 141.1K
- Short balance vs loans
- 44.3%
- How much of the lent stock is sold short. The higher it is, the more buying back a wave of recalls forces.
Who's borrowing: foreign vs domestic
The shares on loan by who borrowed them and who lent them, by value.
- Foreign share, 5 days
- +1.1 pts
- Foreign share, 20 days
- −3.6 pts
- Foreign borrowing, 5 days
- +6.7%
As of Oct 27. Domestic borrowers include Korean brokers, some of which borrow for overseas clients, so this shows who holds the loan, not who finally sells short. Not a recommendation.
Unusual return days (last 60 days)
| Day | Returned | Of the loans | Vs usual |
|---|---|---|---|
| Oct 7 | 476.9K | 42.4% | 13.2× |
| Sep 7 | 286.4K | 26.2% | 13.3× |
| Sep 3 | 86.7K | 7.3% | 4.7× |
| Aug 28 | 46.1K | 5.7% | 3.6× |
| Aug 25 | 46.4K | 5.9% | 4.3× |
| Aug 24 | 38.5K | 5.7% | 3.7× |
Unusual = at least 3× the 20-day average, at least 2% of the shares on loan and 10,000 shares.
As of Oct 27. Published figures, one trading day behind. They describe lending, not where the price goes; not a recommendation.
Lending data: Financial Services Commission, Korea (Public Data Portal).
Retail margin & forced selling
Margin loans
₩30T
−7.3% in 5 days · 8th percentile of the last year
Forced selling
₩11B
0.4× the 20-day average
Forced-sale share
1.0%
Unpaid settlements
₩1T
Retail stock borrowing ₩21B
Calm under 30, normal to 50, elevated to 70, high above. From today's forced-sale amount vs its 20-day average, the forced-sale share of receivables, where margin loans sit in their 1-year range, and whether they are being cut fast.
Estimates from public margin-lending statistics. Not a prediction or a recommendation.
Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Also known as: Samsung Biologics / 삼성바이오로직스 / 207940 / KRX:207940
Source: KRX statistical information